3,6-Dimethoxyflavone

3,6-Dimethoxyflavone

SCHEMBL4649913

COc1ccc2oc(-c3ccccc3)c(OC)c(=O)c2c1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 8/20 1.00
ALDH1A1 P00352 8/20 1.00
HPGD P15428 6/20 1.00
MAPT P10636 5/20 1.00
HSD17B10 Q99714 4/20 1.00
CYP3A4 P08684 3/20 1.00
TSHR P16473 3/20 1.00
CYP2D6 P10635 2/20 1.00
CYP2C9 P11712 2/20 1.00
CYP2C19 P33261 2/20 1.00
TDP1 Q9NUW8 1/20 1.00
MEN1 O00255 1/20 0.80
THRB P10828 1/20 0.80
KMT2A Q03164 1/20 0.80
ABCG2 Q9UNQ0 7/20 0.74
ABCB1 P08183 3/20 0.70
MAOA P21397 1/20 0.65
LMNA P02545 1/20 0.61
ADORA3 P0DMS8 1/20 0.61
NPC1 O15118 2/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14146407 0.90 KDM4E (0.82) KDM4EALDH1A1HPGDMAPTHSD17B10
3,7-Dimethoxyflavone SCHEMBL4278796 0.89 ALDH1A1 (1.00) KDM4EALDH1A1HPGDMAPTHSD17B10
SCHEMBL2119436 0.87 ALDH1A1 (0.77) KDM4EALDH1A1HPGDMAPTHSD17B10
SCHEMBL29167451 0.86 KDM4E (0.76) KDM4EALDH1A1HPGDMAPTHSD17B10
SCHEMBL9387213 0.85 KDM4E (0.74) KDM4EALDH1A1HPGDMAPTHSD17B10
SCHEMBL29993383 0.85 ABCG2 (1.00) KDM4EALDH1A1HPGDMAPTHSD17B10
SCHEMBL253523 0.85 ABCG2 (1.00) KDM4EALDH1A1HPGDMAPTHSD17B10
SCHEMBL2121813 0.85 KDM4E (0.74) KDM4EALDH1A1HPGDMAPTHSD17B10
SCHEMBL1534543 0.85 ALDH1A1 (0.74) KDM4EALDH1A1HPGDMAPTHSD17B10
SCHEMBL30894679 0.85 ALDH1A1 (0.74) KDM4EALDH1A1HPGDMAPTHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008128299-A1 THERAPEUTIC PROTOCOL FOR TREATING HEMOGLOBINOPATHY MURDOCH CHILDRENS RESEARCH INSTITUTE (AU) 2008-10-30 WO claimed
US-6872771-B1 Tire with rubber containing flavone THE GOODYEAR TIRE & RUBBER COMPANY (US) 2005-03-29 US claimed
JP-2003504327-A 2003-02-04 JP claimed
EP-1223928-A2 USE OF FLAVONES, COUMARINS AND RELATED COMPOUNDS TO TREAT INFECTIONS Prendergast, Patrick Thomas (IE) 2002-07-24 EP claimed
WO-2001003681-A2 USE OF FLAVONES, COUMARINS AND RELATED COMPOUNDS TO TREAT INFECTIONS PRENDERGAST PATRICK T (IE) 2001-01-18 WO claimed
US-20220291237-A1 Gene Expression Inflammatory Age and Its Uses Edifice Health, Inc. (US) 2022-09-15 US disclosed
US-10561650-B2 Method for treating a protozoal infection REID CHRISTOPHER BRIAN (US) 2020-02-18 US disclosed
US-20190224193-A1 Compositions of Natural Extracts and Use Thereof in Methods for Preventing or Treating Diseases REID CHRISTOPHER BRIAN (US) 2019-07-25 US disclosed
US-20190008853-A1 METHOD FOR TREATING A PROTOZOAL INFECTION REID CHRISTOPHER BRIAN (US) 2019-01-10 US disclosed
US-20180042899-A1 Method of Treating Transplant Rejection and Autoimmune Diseases NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2018-02-15 US disclosed
WO-2017161387-A1 COMPOSITIONS OF NATURAL EXTRACTS AND USE THEREOF IN METHODS FOR PREVENTING OR TREATING DISEASES REID CHRISTOPHER BRIAN (US) 2017-09-21 WO disclosed
EP-2730431-B1 Rubber composition and tire with rubber containing flavone GOODYEAR TIRE & RUBBER (US) 2017-06-28 EP disclosed
EP-1391327-B1 Tire with rubber containing flavone GOODYEAR TIRE & RUBBER (US) 2008-09-03 EP disclosed
US-6872771-B1 Tire with rubber containing flavone THE GOODYEAR TIRE & RUBBER COMPANY (US) 2005-03-29 US disclosed
EP-1391327-A1 Tire with rubber containing flavone THE GOODYEAR TIRE & RUBBER COMPANY (US) 2004-02-25 EP disclosed
WO-2003057210-A1 COMPOSITIONS AND METHODS FOR INCREASING CELL PROLIFERATION COMPRISING A FLAVONOID KIMBERLY-CLARK WORLDWIDE, INC. (US) 2003-07-17 WO disclosed
US-20030125264-A1 Methods For Treating Wounds KIMBERLY-CLARK WORLDWIDE, INC. 2003-07-03 US disclosed
US-6555523-B1 Such as 3',4'-diacetoxy-5,6,7-trimethoxyflavone or naringin in the treatment HIV, picornavirus, and/or respiratory virus CASCADE ESTATES LTD. (MU) 2003-04-29 US disclosed
EP-1223928-A2 USE OF FLAVONES, COUMARINS AND RELATED COMPOUNDS TO TREAT INFECTIONS Prendergast, Patrick Thomas (IE) 2002-07-24 EP disclosed
WO-2001003681-A2 USE OF FLAVONES, COUMARINS AND RELATED COMPOUNDS TO TREAT INFECTIONS PRENDERGAST PATRICK T (IE) 2001-01-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030125264-A1 Methods For Treating Wounds FGF2, MMP1, FIBP KDM4E 2309/4885ALDH1A1 2440/4885HPGD 558/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.